Evaluation of Pharmacokinetic-Pharmacodynamic Relationships for BioRelease Meloxicam Formulations in Horses
Authors:
- Patrick J. BurnsPBPatrick J. Burns
- Chris MorrowCMChris Morrow
- Richard M. GilleyRGRichard M. Gilley
- Mark G. PapichMPMark G. Papich
- 1 October 2010
- journal article
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 30 (10) , 539-544
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Factors associated with failure of Thoroughbred horses to train and raceEquine Veterinary Journal, 2010
- Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunumAmerican Journal of Veterinary Research, 2009
- The use of force plate measurements to titrate the dosage of a new COX‐2 inhibitor in lame horsesEquine Veterinary Journal, 2009
- Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritisJournal of the American Veterinary Medical Association, 2008
- Effects of the cyclooxygenase inhibitor meloxicam on recovery of ischemia-injured equine jejunumAmerican Journal of Veterinary Research, 2007
- COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: An in vitro analysisPharmacological Research, 2005
- Effects of cyclooxygenase inhibitors flunixin and deracoxib on permeability of ischaemic‐injured equine jejunumEquine Veterinary Journal, 2005
- Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemiaAmerican Journal of Veterinary Research, 2004
- Prospective study of equine colic incidence and mortalityEquine Veterinary Journal, 1997
- Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflammation Research, 1995